BBK Worldwide Extends mHealth Suite With Mobile Streaming Video App Platform
WASHINGTON, DC and BOSTON, MA–(Marketwired – June 15, 2015) – DIA 2015 Annual Meeting — BBK Worldwide, a leading clinical trial marketing firm, today announced My Research Mate℠, a live streaming video app platform developed to educate consumers about cutting-edge treatment options and available clinical research studies, and the importance of clinical research more broadly. The app is intended to offer an enhanced experience through live video interactions with researchers, thought leaders, advocacy groups and even other patients and caregivers — of utmost importance to those struggling with rare and incurable diseases where research advances represent the only option for treatment.
Consumers continue to take the driver’s seat in their own health care and wellness, an evolving shift that will continue to impact clinical studies and help fuel mobile technology adoption across all areas of clinical research. What’s more, consumers increasingly prefer video over other forms of communication. It’s estimated that video will account for 74% of all internet traffic and 33% of tablet owners watch more than an hour of video on their device each day.
In support of these trends and underscoring BBK’s commitment to optimal patient engagement, My Research Mate was designed to leverage the power of video to help improve engagement and support more meaningful information sharing. The challenges that come with a diagnosis or managing an illness are greatly compounded when patients and caregivers lack access to information, and this new offering was built to address that. My Research Mate also allows scientists and researchers to share research news, findings and related trial patient opportunities – and to do so directly and to the right audience.
“mHealth for clinical research continues to evolve quickly as we work as an industry to ensure that patients have greater access to study information — where, when and how they need it,” said Joan F. Bachenheimer, founding principal of BBK Worldwide. “Consider the person exhibiting symptoms of early Alzheimer’s disease, most likely fearful and wishing to deny his or her worries. Investigational treatments are showing promise in delaying the devastating progression of the disease, but are most effective when provided to the patients early on in their disease progression. My Research Mate, through live streaming events and expert commentary, helps these patients better understand their cognitive behaviors — often not related to Alzheimer’s disease — while motivating clinical trial participation when further testing confirms that Alzheimer’s disease is indeed the diagnosis.”
“As mobile apps continue to become a bigger part of the clinical research and healthcare mix, patients will continue to rely on them to stay informed to help better manage their disease or condition — and we believe live streaming video is an important, natural next step,” continued Bachenheimer.
The new video platform will be available as a stand-alone tool and as a password-protected video feature within BBK’s mobile apps for patients and sites, My Clinical Study Buddy® and My Protocol Pal℠ respectively. For additional information, visit MyResearchMate.com, text “Innovate” to 31996 or email [email protected].
Visit BBK booth #2026 at the DIA Annual Meeting to learn more about the company’s software solutions and consulting services for improved patient recruitment and engagement. Members of the media and analyst communities interested in meeting with BBK Worldwide at the show can contact Juli Greenwood at 617-515-8412 or [email protected].
Follow @BBKWorldwide on Twitter and join the conversation with #DIA2015 and #BBKatDIA.
Additional Resources
About BBK Worldwide
With more than three decades of experience across a wide variety of therapies and medicines, BBK Worldwide is the global leader in patient recruitment and engagement for the clinical trial industry. BBK’s innovative software solutions and consulting services leverage the company’s adaptive recruitment methodology to protect global enrollment integrity, specifically within an ever-changing or threatened landscape. For more information, visit www.bbkworldwide.com.
Image Available: http://www.marketwire.com/library/MwGo/2015/6/14/11G044778/Images/MyResearchMate_final-1210016527384.jpg
Source: Marketwired Biotech
